The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Prenatal and Newborn Genetic Testing market was valued at US$ 2154.1 million in 2023 and is anticipated to reach US$ 2917.1 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
North American market for Prenatal and Newborn Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prenatal and Newborn Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Prenatal and Newborn Genetic Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Prenatal and Newborn Genetic Testing include Roche Diagnostic, Elitech Group, Myriad Genetics, Biocartis, IntegraGen, Perkin Elmer, WaferGen Biosystem, Interpace Diagnostics and Quest Diagnostic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prenatal and Newborn Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prenatal and Newborn Genetic Testing.
Report Scope
The Prenatal and Newborn Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prenatal and Newborn Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prenatal and Newborn Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- Roche Diagnostic
- Elitech Group
- Myriad Genetics
- Biocartis
- IntegraGen
- Perkin Elmer
- WaferGen Biosystem
- Interpace Diagnostics
- Quest Diagnostic
- Bio-Rad
- AutoGenomics
- Abbott
- Cepheid
- EKF Diagnostics
- Natera
- Agilent Technologies
- Illumina
- Ariosa Diagnostics
- Sequenom
Segment by Type
- Array-Comparative Genetic Hybridization(aCGH)
- Fluorescence In-Situ Hybridization(FISH)
- Polymerase Chain Reaction(PCR)
Segment by Application
- Hospitals
- Diagnostic Organization
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prenatal and Newborn Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prenatal and Newborn Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Array-Comparative Genetic Hybridization(aCGH)
1.2.3 Fluorescence In-Situ Hybridization(FISH)
1.2.4 Polymerase Chain Reaction(PCR)
1.3 Market by Application
1.3.1 Global Prenatal and Newborn Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Organization
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prenatal and Newborn Genetic Testing Market Perspective (2019-2030)
2.2 Prenatal and Newborn Genetic Testing Growth Trends by Region
2.2.1 Global Prenatal and Newborn Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prenatal and Newborn Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Prenatal and Newborn Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Prenatal and Newborn Genetic Testing Market Dynamics
2.3.1 Prenatal and Newborn Genetic Testing Industry Trends
2.3.2 Prenatal and Newborn Genetic Testing Market Drivers
2.3.3 Prenatal and Newborn Genetic Testing Market Challenges
2.3.4 Prenatal and Newborn Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prenatal and Newborn Genetic Testing Players by Revenue
3.1.1 Global Top Prenatal and Newborn Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Prenatal and Newborn Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Prenatal and Newborn Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prenatal and Newborn Genetic Testing Revenue
3.4 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio
3.4.1 Global Prenatal and Newborn Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prenatal and Newborn Genetic Testing Revenue in 2023
3.5 Prenatal and Newborn Genetic Testing Key Players Head office and Area Served
3.6 Key Players Prenatal and Newborn Genetic Testing Product Solution and Service
3.7 Date of Enter into Prenatal and Newborn Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prenatal and Newborn Genetic Testing Breakdown Data by Type
4.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Prenatal and Newborn Genetic Testing Breakdown Data by Application
5.1 Global Prenatal and Newborn Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Prenatal and Newborn Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prenatal and Newborn Genetic Testing Market Size (2019-2030)
6.2 North America Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prenatal and Newborn Genetic Testing Market Size by Country (2019-2024)
6.4 North America Prenatal and Newborn Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prenatal and Newborn Genetic Testing Market Size (2019-2030)
7.2 Europe Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prenatal and Newborn Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Prenatal and Newborn Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Prenatal and Newborn Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Prenatal and Newborn Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prenatal and Newborn Genetic Testing Market Size (2019-2030)
9.2 Latin America Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prenatal and Newborn Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Prenatal and Newborn Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Prenatal and Newborn Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Prenatal and Newborn Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche Diagnostic
11.1.1 Roche Diagnostic Company Detail
11.1.2 Roche Diagnostic Business Overview
11.1.3 Roche Diagnostic Prenatal and Newborn Genetic Testing Introduction
11.1.4 Roche Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.1.5 Roche Diagnostic Recent Development
11.2 Elitech Group
11.2.1 Elitech Group Company Detail
11.2.2 Elitech Group Business Overview
11.2.3 Elitech Group Prenatal and Newborn Genetic Testing Introduction
11.2.4 Elitech Group Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.2.5 Elitech Group Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Detail
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Prenatal and Newborn Genetic Testing Introduction
11.3.4 Myriad Genetics Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.3.5 Myriad Genetics Recent Development
11.4 Biocartis
11.4.1 Biocartis Company Detail
11.4.2 Biocartis Business Overview
11.4.3 Biocartis Prenatal and Newborn Genetic Testing Introduction
11.4.4 Biocartis Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.4.5 Biocartis Recent Development
11.5 IntegraGen
11.5.1 IntegraGen Company Detail
11.5.2 IntegraGen Business Overview
11.5.3 IntegraGen Prenatal and Newborn Genetic Testing Introduction
11.5.4 IntegraGen Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.5.5 IntegraGen Recent Development
11.6 Perkin Elmer
11.6.1 Perkin Elmer Company Detail
11.6.2 Perkin Elmer Business Overview
11.6.3 Perkin Elmer Prenatal and Newborn Genetic Testing Introduction
11.6.4 Perkin Elmer Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.6.5 Perkin Elmer Recent Development
11.7 WaferGen Biosystem
11.7.1 WaferGen Biosystem Company Detail
11.7.2 WaferGen Biosystem Business Overview
11.7.3 WaferGen Biosystem Prenatal and Newborn Genetic Testing Introduction
11.7.4 WaferGen Biosystem Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.7.5 WaferGen Biosystem Recent Development
11.8 Interpace Diagnostics
11.8.1 Interpace Diagnostics Company Detail
11.8.2 Interpace Diagnostics Business Overview
11.8.3 Interpace Diagnostics Prenatal and Newborn Genetic Testing Introduction
11.8.4 Interpace Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.8.5 Interpace Diagnostics Recent Development
11.9 Quest Diagnostic
11.9.1 Quest Diagnostic Company Detail
11.9.2 Quest Diagnostic Business Overview
11.9.3 Quest Diagnostic Prenatal and Newborn Genetic Testing Introduction
11.9.4 Quest Diagnostic Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.9.5 Quest Diagnostic Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Company Detail
11.10.2 Bio-Rad Business Overview
11.10.3 Bio-Rad Prenatal and Newborn Genetic Testing Introduction
11.10.4 Bio-Rad Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.10.5 Bio-Rad Recent Development
11.11 AutoGenomics
11.11.1 AutoGenomics Company Detail
11.11.2 AutoGenomics Business Overview
11.11.3 AutoGenomics Prenatal and Newborn Genetic Testing Introduction
11.11.4 AutoGenomics Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.11.5 AutoGenomics Recent Development
11.12 Abbott
11.12.1 Abbott Company Detail
11.12.2 Abbott Business Overview
11.12.3 Abbott Prenatal and Newborn Genetic Testing Introduction
11.12.4 Abbott Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.12.5 Abbott Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Detail
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Prenatal and Newborn Genetic Testing Introduction
11.13.4 Cepheid Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.13.5 Cepheid Recent Development
11.14 EKF Diagnostics
11.14.1 EKF Diagnostics Company Detail
11.14.2 EKF Diagnostics Business Overview
11.14.3 EKF Diagnostics Prenatal and Newborn Genetic Testing Introduction
11.14.4 EKF Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.14.5 EKF Diagnostics Recent Development
11.15 Natera
11.15.1 Natera Company Detail
11.15.2 Natera Business Overview
11.15.3 Natera Prenatal and Newborn Genetic Testing Introduction
11.15.4 Natera Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.15.5 Natera Recent Development
11.16 Agilent Technologies
11.16.1 Agilent Technologies Company Detail
11.16.2 Agilent Technologies Business Overview
11.16.3 Agilent Technologies Prenatal and Newborn Genetic Testing Introduction
11.16.4 Agilent Technologies Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.16.5 Agilent Technologies Recent Development
11.17 Illumina
11.17.1 Illumina Company Detail
11.17.2 Illumina Business Overview
11.17.3 Illumina Prenatal and Newborn Genetic Testing Introduction
11.17.4 Illumina Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.17.5 Illumina Recent Development
11.18 Ariosa Diagnostics
11.18.1 Ariosa Diagnostics Company Detail
11.18.2 Ariosa Diagnostics Business Overview
11.18.3 Ariosa Diagnostics Prenatal and Newborn Genetic Testing Introduction
11.18.4 Ariosa Diagnostics Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.18.5 Ariosa Diagnostics Recent Development
11.19 Sequenom
11.19.1 Sequenom Company Detail
11.19.2 Sequenom Business Overview
11.19.3 Sequenom Prenatal and Newborn Genetic Testing Introduction
11.19.4 Sequenom Revenue in Prenatal and Newborn Genetic Testing Business (2019-2024)
11.19.5 Sequenom Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
